Freshfields advised Roivant Sciences Ltd. in the sale of Dermavant Sciences Ltd. to Organon & Co. Dermavant is a Roivant subsidiary dedicated to developing and commercializing innovative therapeutics in immuno-dermatology. Organon agreed to acquire Dermavant for aggregate consideration of up to approximately $1.2 billion.
More information about the transaction can be found here.
The Freshfields team included corporate/M&A partners Damien Zoubek, Jenny Hochenberg and Tomas Rua, corporate/M&A associate Annie Powderly and life sciences counsel Jeff Jay.
Associates Nana Kessie, Nicole Johnson, Wicy Wang and Patrick Boldea also advised on corporate/M&A matters; associates Jake Silvers, Shannon O’Hara and Dylan O’Connor also advised on life sciences matters; partner Lori Goodman, senior associate Andrew Herman and associate Lina Zhu advised on employee compensation and benefits matters; partner Steven Matays, senior associate Brendan Counihan and associates Hannah Golden and Dominik Luczak advised on tax matters; partners Meghan Rissmiller and Rod Carlton, special counsel Charles Ramsey, senior associates Vadim Egoul and Alessandra Galea and associate Emily Strickland advised on antitrust and competition matters; partners Christine Lyon and Brock Dahl and associate Christine Chong advised on data privacy and security matters and partner Stephanie Brown-Cripps and associate Maylin Meisenheimer advised on sanctions matters.
Where the legal industry reads first.
Enjoyed this article? Get the biggest legal industry updates, deals, appointments, insights and expert interviews in your inbox, free.
No spam. Unsubscribe anytime.
